SSWM Commences Remediation Contract in Mexico; Manufacturing Company to use BUGS Biotechnology for Site Clean-Up.CARLSBAD, Calif. -- Sub-Surface Waste Management of Delaware, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :SSWM SSWM Surface and Storm Water Management ) announced it has mobilized personnel to commence a new contract, with potential total project value up to one million dollars, with a confidential company with operations in Mexico to remediate sub surface soils, upgrade toxic material handling equipment and housekeeping procedures at this active production facility site. Bruce Beattie, President of SSWM, stated, "SSWM engineers will kick-off this exciting project by meeting with the client, its licensee Grupo Bartlett, S.A. de C.V. and representatives from SEMARNAT SEMARNAT Secretaría de Medio Ambiente Y Recursos Naturales (México) (Mexico EPA EPA eicosapentaenoic acid. EPA abbr. eicosapentaenoic acid EPA, n.pr See acid, eicosapentaenoic. EPA, n. ) to commence the work plan prepared by SSWM who had previously completed a site investigation contract to engineer a remedial plan using proprietary microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. blends to bioremediate the constituents of concern inadvertently released. SSWM licensed U.S. Patented systems deliver and maintain a bio-reaction beneath the facility floor and will remediate excavated soils using the patented Bio-Raptor(TM) treatment system, turning toxics into harmless carbon dioxide carbon dioxide, chemical compound, CO2, a colorless, odorless, tasteless gas that is about one and one-half times as dense as air under ordinary conditions of temperature and pressure. and water. The microbial blends used are natural 'non-genetically' engineered and approved as safe by the U.S. Department of Agriculture and are approved and registered in Mexico with SEMARNAT through Grupo Bartlett." SSWM and Grupo Bartlette received official notification from Mexico's SEMARNAT agency that SSWM's licensed U.S. Patented bioremediation bi·o·re·me·di·a·tion n. The use of biological agents, such as bacteria or plants, to remove or neutralize contaminants, as in polluted soil or water. technologies were approved for use throughout Mexico for cleanup of soils and water impacted by petroleum hydrocarbon wastes. At the time of approval, the technology was one of five registered and approved cleanup treatment technologies in Mexico giving the company a competitive advantage. About Sub-Surface Waste Management A subsidiary of U.S. Microbics (OTCBB:BUGS), Sub-Surface Waste Management of Delaware, Inc. provides comprehensive civil and environmental engineering project management services including specialists to design, permit, build and operate environmental waste clean-up treatment systems using conventional, biological and filtration technologies. SSWM is capitalizing on its expertise and technology by forming strategic alliances and joint ventures with well-established engineering firms. Investors and media contact Bruce Beattie at 760/918-1860, ext. 105 or bbeattie@bugsatwork.com; or learn about the company by visiting its Web site at www.bugsatwork.com/19.asp. The information contained in this press release includes forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . Forward-looking statements usually contain the words "estimate," "anticipate," "believe," "expect" or similar expressions that involve risks and uncertainties. These risks and uncertainties include the company's status as a startup company The creator of this article, or someone who has substantially contributed to it, may have a conflict of interest regarding its subject matter. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. with uncertain profitability, need for significant capital, uncertainty concerning market acceptance of its products, competition, limited service and manufacturing facilities, dependence on technological developments and protection of its intellectual property. The company's actual results could differ materially from those discussed herein. Factors that could cause or contribute to such differences are discussed more fully in the "Risk Factors," "Management's Discussion and Analysis Management's discussion and analysis (MD&A) A report from management to shareholders that accompanies the firm's financial statements in the annual report. It explains the period's financial results and enables management to discuss topics that may not be apparent in the financial or Plan of Operation" and other sections of the company's Form 10-KSB and other publicly available information regarding the company on file with the Securities and Exchange Commission. The company will provide you with copies of this information upon request. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion